Lung Cancer

Sometimes in life, we are fortunate enough to meet an individual who inspires us, motivating us to be our best. I was fortunate to meet Valerie “Val” Betancourt, M.S.N., RN, NP-C, OCN, over 20 years ago. Little did I know this was going to be the beginning of a wonderful friendship.

From landmark Senate legislation to the Pink Lemonade Stand Challenge, here’s what is making headlines in the cancer space this week.

GO2 Foundation will recognize Prof. Peters at the 20th International Lung Cancer Congress for her leadership in lung cancer research.

GO2 Foundation will recognize Prof. Peters at the 20th International Lung Cancer Congress for her leadership in lung cancer research.

Given with each dose of chemotherapy, trilaciclib temporarily puts bone marrow to sleep, helping to prevent fevers, infections and hospital stays in patients with small cell lung cancer.

Nominee for CURE®’s 2019 Extraordinary Healer® award, oncology nurse Megan Roy’s insight is valued and trusted by both patients and her team, making care processes smooth no matter whether she worked directly with patients or not.

From today’s top performers and athletes to surprising findings about prostate cancer treatment, here’s what is making headlines in the cancer space this week.

One expert weighs the benefits and drawbacks of expanding clinical trials to be more inclusive and reflective of the general patient population with cancer.

Studies show that the social stigma can actually affect a patient’s level of care and lead to worse health outcomes.

Tumor mutation burden may be an independent predictor of developing depression in patients with lung cancer, according to Dr. Daniel McFarland.

The growing use of telecommunication and technology to provide health care – or telemedicine – offers many advantages, but also comes with challenges, says one expert.

Trilaciclib, an intravenous CDK 4/6 inhibitor, in combination with Hycamtin may reduce chemotherapy-induced myelosuppression in small cell lung cancer, according to one expert.

From cancer-sniffing dogs to music therapy for pain, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration approved Keytruda for the treatment of patients with metastatic small cell lung cancer.

Autoimmune skin toxicities in patients with non-small cell lung cancer mean patients may respond better to immune checkpoint inhibitors.

In this week’s episode of the “CURE® Talks Cancer” podcast, we spoke with a caregiver who found hope in the darkness after losing her son to lung cancer at just 29 years old.

I have stage 4 lung cancer and told I had 12-18 months to live. Little did I know they sent a biopsy off for genome testing which has given me six years so far. My life is incredibly imperfect, but I love every single minute of it.

Jennifer King, from the GO2 Foundation for Lung Cancer, discussed what patients can do to help address the stigma associated with lung cancer.

Genomic testing has transformed the therapeutic landscape of lung cancer in recent years, but there is still room for improvement, says one expert.

Here are the top 5 CURE stories for May 2019.

Precision medicine has prolonged life for many with lung cancer, giving them opportunities to support those who are newly diagnosed.

"Alvin David, B.S.N., RN-BC, wrote this exemplar as part of his promotion to clinical nurse 3. I will let his words do the talking, as they reveal his true essence as a nurse, colleague, preceptor, friend, father, husband and extraordinary healer," wrote Margie McDonald, M.S.N., RN, CBCN of Memorial Sloan Kettering Monmouth.

We've got a sneak peek at what’s inside CURE®'s lung cancer special issue.

With nearly 30 years of experience in thoracic oncology, one expert discusses what lies ahead for patients with small cell lung cancer.

LUNGevity’s annual summit helps people with lung cancer live better and stay informed.

Thousands of new patients are now able to enroll in Lung Cancer Master Cancer Protocol, a National Cancer Institute trial. Criteria have been expanded to allow patients with all types of non-small cell lung cancer.

Two husbands embrace changing and challenging roles at home when they learn of their spouses’ cancer diagnoses.

A pre-surgical shape-up could improve recovery for patients with lung cancer. Although the findings are still emerging, some researchers think that prehab may be a key player that will improve patient outcomes in this changing environment.

Testing for genomic mutations in lung cancer helps pinpoint targeted therapies.